These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 7131480
1. Synthesis and immunoadjuvant activities of 2-acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O-[(R)-2-propionyl-L-alanyl-D- isoglutamine]-D-glucofuranoses as potential prodrug forms of 6-O-Acyl Derivatives of N-acetylmuramyl dipeptide. Durette PL, Dorn CP, Friedman A, Schlabach A. J Med Chem; 1982 Sep; 25(9):1028-33. PubMed ID: 7131480 [Abstract] [Full Text] [Related]
4. Chemical modification of the C-6 substituent in the carbohydrate moiety of N-acetylmuramoyl-L-alanyl-D-isoglutamine (MDP), and the immunoadjuvant activity. Okumura H, Tokushima Y, Saiki I, Azuma I, Kiso M, Hasegawa A. Carbohydr Res; 1983 Oct 14; 122(1):87-98. PubMed ID: 6652634 [Abstract] [Full Text] [Related]
5. Synthesis and reactions of O-acetylated benzyl alpha-glycosides of 6-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-N-acetylmuramoyl-L- alanyl-D-isoglutamine esters: the base-catalysed isoglutamine in equilibrium glutamine rearrangement in peptidoglycan-related structures. Keglević D, Derome AE. Carbohydr Res; 1989 Feb 15; 186(1):63-75. PubMed ID: 2720705 [Abstract] [Full Text] [Related]
6. Synthesis of carbohydrate analogs (positional, configurational, and optical) of n-acetylmuramoyl-L-alanyl-D-isoglutamine, and their immunoadjuvant activities. Hasegawa A, Kaneda Y, Goh Y, Nishibori K, Kiso M, Azuma I. Carbohydr Res; 1981 Aug 01; 94(2):143-63. PubMed ID: 7273036 [Abstract] [Full Text] [Related]
9. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats. Kohashi O, Kohashi Y, Shigematsu N, Ozawa A, Kotani S. Lab Invest; 1986 Sep 01; 55(3):337-46. PubMed ID: 3489128 [Abstract] [Full Text] [Related]
15. Synthesis and immunoadjuvant activity of N-[2-O-(2-acetamido-2,3,di-deoxy-6-thio-D-glucopyranose-3-yl)-D-lac toy l]-L- alanyl-D-isoglutamine derivatives. Hasegawa A, Seki E, Hioki Y, Kiso M, Azuma I. Carbohydr Res; 1984 Jul 01; 129():271-7. PubMed ID: 6467247 [No Abstract] [Full Text] [Related]
17. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen. Yang HZ, Xu S, Liao XY, Zhang SD, Liang ZL, Liu BH, Bai JY, Jiang C, Ding J, Cheng GF, Liu G. J Med Chem; 2005 Aug 11; 48(16):5112-22. PubMed ID: 16078831 [Abstract] [Full Text] [Related]
18. Synthesis and immunoadjuvant activity of N-[2-O-(2-acetamido- 1,2,3,5-tetradeoxy-1,5-imino-D-glucitol-3-yl)-D-lactoyl]- L-alanyl-D-isoglutamine. Ishida H, Kitagawa M, Kiso M, Hasegawa A, Azuma I. Carbohydr Res; 1990 Dec 15; 208():267-72. PubMed ID: 2085813 [No Abstract] [Full Text] [Related]
19. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine). Mozes E, Sela M, Chedid L. Proc Natl Acad Sci U S A; 1980 Aug 15; 77(8):4933-7. PubMed ID: 6776530 [Abstract] [Full Text] [Related]
20. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs. Parant MA, Audibert FM, Chedid LA, Level MR, Lefrancier PL, Choay JP, Lederer E. Infect Immun; 1980 Mar 15; 27(3):826-31. PubMed ID: 7380554 [Abstract] [Full Text] [Related] Page: [Next] [New Search]